SR

Sofiya Rani

Active Director Director DIN 11486616
DIN 11486616 First appointment Jan 2026 Primary industry Chemicals
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Jan 2026
Shareholding value •••• Premium profile

About Sofiya Rani

Data last updated:

Sofiya Rani is a Director at Lyvix Lifescience Private Limited (since 2026). The company operates in Chemicals. Lyvix Lifescience Private Limited reported revenue of ₹11.6 Lakh (FY 2025).

DIN 11486616
Primary Designation Director
Industry Chemicals
First Appointment 19 Jan 2026
Largest company Lyvix Lifescience Private Limited · ₹11.6 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Lyvix Lifescience Private Limited U24230UP2022PTC169478
Director19 Jan 2026₹11.6 Lakh (FY 2025)Active

Board colleagues of Sofiya Rani

NameDINCompanyDesignation
Usha Gupta09714030Lyvix Lifescience Private LimitedDirector

Directorship timeline

Open interactive timeline →
Lyvix Lifescience Private Limited
Premium access

Shareholding and investment profile for Sofiya Rani

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sofiya Rani

Sofiya Rani currently holds 1 directorship: Lyvix Lifescience Private Limited (Director, since 19 Jan 2026, revenue ₹11.6 Lakh (FY 2025)).

Sofiya Rani was first appointed on 19 Jan 2026 as Director at Lyvix Lifescience Private Limited.

The current boards of Sofiya Rani's companies include Usha Gupta (Lyvix Lifescience Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available